Literature DB >> 10568196

Pharmacologic stimulation of adenosine A2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers.

H Nakayama1, Y Yamamoto, M Kume, K Yamagami, H Yamamoto, S Kimoto, Y Ishikawa, N Ozaki, Y Shimahara, Y Yamaoka.   

Abstract

BACKGROUND: Ischemic preconditioning (IPC) is a promising strategy for conferring ischemic tolerance. We confirmed the acquisition of ischemic tolerance in the liver immediately after IPC and the role of adenosine kinetics in this process.
METHODS: Male Lewis rats were used. IPC was administered with a 10-minute ischemia followed by a 10-minute reperfusion. Ischemic tolerance was tested with a 45-minute ischemia. Changes in the adenosine concentrations in liver tissue were evaluated, and the effects of adenosine A1 or A2 receptor agonists or antagonists were examined either in place of or against IPC.
RESULTS: The 7-day animal survival was significantly better in the IPC group than in the control group (87% vs 53%; n = 15, P < .05). The release of liver-related enzymes during reperfusion was suppressed better in the IPC group (P < .01). Recovery of adenosine triphosphate levels was faster in the IPC group (P < .01). After IPC, adenosine concentrations in liver tissue immediately increased to 1555 +/- 299 pmol/g wet tissue and were maintained at that level during a subsequent 45-minute ischemia. The ischemic tolerance generated by IPC was mimicked by the administration of adenosine A2 receptor agonist and opposed by adenosine A2 receptor antagonist.
CONCLUSIONS: The ischemic tolerance of the liver immediately after IPC can be supplanted by selective pharmacologic stimulation of adenosine A2 receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568196     DOI: 10.1016/s0039-6060(99)70037-1

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

Review 1.  Molecular mechanisms of liver preconditioning.

Authors:  Elisa Alchera; Caterina Dal Ponte; Chiara Imarisio; Emanuele Albano; Rita Carini
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.

Authors:  Melanie L Hart; Iris C Gorzolla; Jens Schittenhelm; Simon C Robson; Holger K Eltzschig
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

Review 3.  Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species.

Authors:  Hartmut Jaeschke; Benjamin L Woolbright
Journal:  Transplant Rev (Orlando)       Date:  2012-04       Impact factor: 3.943

4.  The strategy of combined ischemia preconditioning and salvianolic acid-B pretreatment to prevent hepatic ischemia-reperfusion injury in rats.

Authors:  Rui Kong; Yue Gao; Bei Sun; Hua Chen; Gang Wang; Xiuyun Wang; Hong Zhu; Shangha Pan; Dongbo Xue; Hongchi Jiang
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

5.  Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors.

Authors:  Seong G Kim; Kelly A Soltysiak; Zhan-Guo Gao; Tong-Shin Chang; Eunju Chung; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2003-03-15       Impact factor: 5.858

6.  Protective Effects of Adenosine Receptor Agonist in a Cirrhotic Liver Resection Model.

Authors:  Emil Iskandarov; Pramod Kadaba Srinivasan; Wang Xin; Christian Bleilevens; Mamdouh Afify; Astrit Hamza; Lai Wei; Koichiro Hata; Boyukkishi Agayev; Rene Tolba
Journal:  Hepat Mon       Date:  2016-07-24       Impact factor: 0.660

Review 7.  Beyond Preconditioning: Postconditioning as an Alternative Technique in the Prevention of Liver Ischemia-Reperfusion Injury.

Authors:  Kassiani Theodoraki; Iosifina Karmaniolou; Aliki Tympa; Marios-Konstantinos Tasoulis; Constantinos Nastos; Ioannis Vassiliou; Nikolaos Arkadopoulos; Vassilios Smyrniotis
Journal:  Oxid Med Cell Longev       Date:  2016-06-02       Impact factor: 6.543

Review 8.  An Evaluation of Ischaemic Preconditioning as a Method of Reducing Ischaemia Reperfusion Injury in Liver Surgery and Transplantation.

Authors:  Francis P Robertson; Barry J Fuller; Brian R Davidson
Journal:  J Clin Med       Date:  2017-07-14       Impact factor: 4.241

9.  Ischemia/Reperfusion Injury of Fatty Liver Is Protected by A2AR and Exacerbated by A1R Stimulation through Opposite Effects on ASK1 Activation.

Authors:  Elisa Alchera; Bangalore R Chandrashekar; Nausicaa Clemente; Ester Borroni; Renzo Boldorini; Rita Carini
Journal:  Cells       Date:  2021-11-15       Impact factor: 6.600

Review 10.  Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype.

Authors:  Elisa Alchera; Chiara Imarisio; Giorgia Mandili; Simone Merlin; Bangalore R Chandrashekar; Francesco Novelli; Antonia Follenzi; Rita Carini
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.